- Current languageen
Pharmaceuticals - Community Register
Community register of veterinary medicinal products
|Invented name:||Poulvac E. coli|
|Auth. number :||EU/2/12/140|
|INN :||Live aroA gene deleted Escherichia coli, type O78, strain EC34195|
|ATC:||Anatomical main group: QI - Immunologicals|
Therapeutic subgroup: QI01 - Immunologicals for aves
Pharmacological subgroup: QI01A - Domestic fowl
Chemical subgroup: QI01AE - Live bacterial vaccines
Chemical substance: QI01AE04 - Escherichia
(See WHO ATCvet Index)
|Indication:||For active immunisation of broiler chickens and future layer/breeders in order to reduce mortality and|
lesions (pericarditis, perihepatitis, airsacculitis) associated with Escherichia coli serotype O78.
Onset of immunity: 2 weeks after vaccination for the reduction of lesions. The onset of immunity has
not been established for the mortality claim. Duration of immunity: 8 weeks after vaccination has been demonstrated for the reduction of lesions
and 12 weeks after vaccination for the reduction of mortality.
A cross protection study showed reduction of incidence and severity of airsacculitis caused by E. coli
serotypes O1, O2 and O18. For these serotypes no onset of immunity or duration of immunity was
|Marketing Authorisation Holder:||Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-La-Neuve, Belgique
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".|
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|20/06/2012||Centralised - Authorisation||EMEA/V/C/2007||(2012)4207 of 15/06/2012|
|24/05/2013||Centralised - Transfer Marketing Authorisation Holder||EMEA/V/C/2007/T/1||(2013)3099 of 22/05/2013|
|12/07/2013||Centralised - Variation||EMEA/V/C/2007/IB/2/G|
|05/09/2013||Centralised - Variation||EMEA/V/C/2007/IA/3/G|